These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35387678)

  • 1. Harm reduction readiness for illicit IV drug use among safety-net primary care practices in the San Fernando Valley.
    Kalinoski T; DeWitt C; Belani H
    Arch Public Health; 2022 Apr; 80(1):110. PubMed ID: 35387678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs.
    Nolan NS; Fracasso Francis SM; Marks LR; Beekmann SE; Polgreen PM; Liang SY; Durkin MJ
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad402. PubMed ID: 37593531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigating the Risk of Infectious Diseases Among Rural Drug Users in Western North Carolina: Results of the Southern Appalachia Test, Link, Care (SA-TLC) Health Care Provider Survey.
    Hurt CB; Carpenter DM; Evon DM; Hennessy CM; Rhea SK; Zule WA
    J Rural Health; 2020 Mar; 36(2):208-216. PubMed ID: 31742771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.
    Hilton BA; Thompson R; Moore-Dempsey L; Janzen RG
    J Adv Nurs; 2001 Feb; 33(3):357-70. PubMed ID: 11251723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS knowledge and attitudes among injection drug users: the issue of reliability.
    Longshore D; Hsieh SC; Anglin MD
    AIDS Educ Prev; 1992; 4(1):29-40. PubMed ID: 1543642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Clinician Knowledge, Attitudes, and Practices Relating to Nonpharmaceutical Fentanyl and Harm Reduction.
    Whitney E; Weyer G; Perri M; Dickson S; Kerins A; Landi AJ; Moore PQ; Murray JP; Pucci G; Ari M
    Subst Use Addctn J; 2024 Aug; ():29767342241266421. PubMed ID: 39087695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018.
    Ohringer AR; Serota DP; McLean RL; Stockman LJ; Watt JP
    BMC Public Health; 2021 Jul; 21(1):1435. PubMed ID: 34289822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV risk behavior among injection drug users in Tehran, Iran.
    Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
    Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of Taiwan's implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017.
    Chen WJ; Chen CY; Wu SC; Wu KC; Jou S; Tung YC; Lu TP
    Harm Reduct J; 2021 Nov; 18(1):117. PubMed ID: 34798883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative exploration of health care workers' approaches to relational harm reduction in HIV primary care settings.
    Kay ES; Creasy SL; Townsend J; Hawk M
    Harm Reduct J; 2024 May; 21(1):97. PubMed ID: 38760824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
    Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
    J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.
    Thakarar K; Rokas KE; Lucas FL; Powers S; Andrews E; DeMatteo C; Mooney D; Sorg MH; Valenti A; Cohen M
    PLoS One; 2019; 14(11):e0225460. PubMed ID: 31770395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: a quantitative systematic review protocol.
    Clarke DE; Gonzalez M; Pereira A; Boyce-Gaudreau K; Waldman C; Demczuk L
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):133-45. PubMed ID: 26571289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
    Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
    Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Qualitative Exploration of Providers' Approaches to Relational Harm Reduction in HIV Primary Care Settings.
    Kay ES; Creasy S; Townsend J; Hawk M
    Res Sq; 2024 Mar; ():. PubMed ID: 38586007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico.
    Robles RR; Colón HM; Díaz N; Cancel LI; MacGowan R; Cole GE; Allen DM
    Int J Epidemiol; 1994 Jun; 23(3):595-601. PubMed ID: 7960388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
    Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; ; Comiskey C; Rossi C; Griffiths P
    Harm Reduct J; 2017 Apr; 14(1):19. PubMed ID: 28431584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.